At a Glance
Dosage
oral
| Level | MiPLA | DOI |
|---|---|---|
| Threshold | 50 µg | 0.5 mg |
| Light | 100–150 µg | 0.5–1 mg |
| Common | 150–200 µg | 1–2 mg |
| Strong | 200–250 µg | 2–3 mg |
| Heavy | 300 µg | 3 mg |
Duration
oral
MiPLA
oral
Total: 4 hrs – 6 hrsCome Up
Peak
Offset
Onset20 min – 40 min
Come Up45 min – 1.5 hrs
Peak1 hrs – 2 hrs
Offset1 hrs – 2 hrs
DOI
Effects
Safety
Interaction: MiPLA + DOI
No direct interaction data available between these substances. This does not mean the combination is safe.
MiPLA — Dangerous Interactions
No dangerous interactions recorded.
DOI — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between MiPLA and DOI?
MiPLA is classified as a Psychedelic (Lysergamides) while DOI is classified as a Psychedelic (Substituted amphetamines). They share 51 effects in common, with 16 effects unique to MiPLA and 15 unique to DOI.
Is it safe to combine MiPLA and DOI?
There is no direct interaction data available for combining MiPLA and DOI. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, MiPLA or DOI?
At common doses via oral, MiPLA is typically dosed at 150–200 µg while DOI is dosed at 1–2 mg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.